The development of IR in lipotoxic conditions (human studies and rat NAFLD model) is associated with an increase in PKC activity, suggesting that PKC-activating action of DAG is at least in part involved in the mechanism of FFA-mediated IR induction [43,212,213]. The gene discussed is PRRT2; the disease is metabolic dysfunction-associated steatotic liver disease.